Panobinostat (Pan), a pan-HDAC inhibitor (HDACi), has demonstrated efficacy against pancreatic cancer cells by inducing apoptosis and impeding cell proliferation at nanomolar concentrations [12,13]. Here, HDAC9 is linked to familial pancreatic carcinoma.